Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic Variants in the Transcription Factor Network: The Impact of <i>FOXC1, NOTCH1, RORC, FOXC</i>2 and <i>SOX18</i> in Primary Lymphedema.

Lymphology·2025
Same author

Improvement of psoriasis following initiation of biologic therapy is associated with lower risk of developing psoriatic arthritis: A single-center, retrospective, cohort study.

Journal of the American Academy of Dermatology·2025
Same author

Tirbanibulin 1% real-world use in 679 actinic keratoses patients during warm season (SUMM-AK study).

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Primary Cutaneous B-Cell Lymphomas: An Updated Portrait of Classification, Biology, and Clinical Management.

European journal of haematology·2025
Same author

Genetic Variants in <i>LZTR1, MAP2K1</i> and <i>RAF1</i>: Insights into the Role of RAS-MAPK Pathway in Primary Lymphedema.

Lymphology·2025
Same author

Genetic Study of HGF-MET Signaling Pathway in Primary Lymphedema Patients: Supporting Evidence for Loss of Function Variants in HGF.

Lymphology·2025

Related Experiment Video

Updated: Jul 10, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.5K

Omics sciences and precision medicine in melanoma.

M C Medori1, K Donato2,3, K Dhuli1

  • 1MAGI'S LAB, Rovereto (TN), Italy.

La Clinica Terapeutica
|November 23, 2023
PubMed
Summary

Omics sciences, including genomics and proteomics, are revolutionizing melanoma research by identifying new therapeutic targets and diagnostic biomarkers. This approach enhances our understanding of melanoma complexity for improved patient outcomes.

Keywords:
Melanomadiagnosisgenomicsmetabolomicsomics scienceprecision medicinetherapy

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

15.8K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

12.4K

Related Experiment Videos

Last Updated: Jul 10, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.5K
A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

15.8K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

12.4K

Area of Science:

  • Biomedical Research
  • Genomics
  • Proteomics

Background:

  • Omics sciences involve large-scale analysis of biological molecules like DNA, RNA, proteins, and metabolites.
  • These approaches are crucial for unraveling the complexity of melanoma.

Purpose of the Study:

  • To provide an overview of omics sciences applications in melanoma research.
  • To highlight key findings and future directions in the field.

Main Methods:

  • Focused research strategy with systematic examination of scientific literature.
  • Selection of pertinent articles on omics in melanoma.

Main Results:

  • Omics approaches (genomics, transcriptomics, proteomics, metabolomics) are essential tools in melanoma research.
  • Studies have identified novel therapeutic targets and biomarkers for melanoma diagnosis and prognosis.
  • Integration of multi-omics data and personalized medicine are key future directions.

Conclusions:

  • Omics science is vital for advancing melanoma understanding.
  • This field holds significant potential for improving patient outcomes in melanoma care.